Research indicates that Pterostilbene can more effectively prevent azoxymethane (AOM)-induced colon cancer by activating the antioxidant signaling pathway mediated by NF-E2-related factor 2 (Nrf2) compared to RES (99). This evidence concerns the gene NFE2L2 and malignant colon neoplasm.